BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Caliper Life Sciences (CALP) and Carestream Health, Inc. Settle Lawsuits


8/8/2011 11:55:00 AM

HOPKINTON, Mass., Aug. 8, 2011 /PRNewswire/ -- Caliper Life Sciences, Inc. (NASDAQ: CALP) today announced that it has favorably settled two lawsuits with Carestream Health, Inc.

In the first lawsuit, filed in February 2010, Caliper, its wholly owned subsidiary, Xenogen, and Stanford University alleged that Carestream's marketing and sales of its instrument systems induced infringement of seven imaging patents that are exclusively licensed to Xenogen by Stanford University.

In the second lawsuit, filed in July 2010, Carestream alleged that Caliper's Lumina XR system infringed a Carestream imaging patent (U.S. Patent No. 7,734,325).

To settle these lawsuits, Carestream and Caliper have agreed (i) to dismiss their respective claims and counterclaims; (ii) that Carestream will not market and sell in-vivo optical imaging systems for certain applications covered by patents licensed from Stanford by Xenogen and Caliper; and (iii) that Carestream will not assert that the Lumina XR system as currently configured and sold by Caliper infringes any of Carestream's patents.

Caliper was represented by Mark Fox Evens and Eldora Ellison, Ph.D. of the law firm Sterne, Kessler, Goldstein & Fox, P.L.L.C. The two suits are (i) Caliper Life Sciences, et al. v. Carestream Health., Civil Action No.: 4:10-cv-02079-PJH (N.D.Ca.) & (ii) Carestream Health, Inc. v. Caliper Life Sciences, Case No.: 10-cv-00381(WMC)(SLC) (W.D.Wis.).

About Caliper Life Sciences

Caliper Life Sciences is a premier provider of cutting-edge technologies enabling researchers in the life sciences industry to create life-saving and enhancing medicines and diagnostic tests more quickly and efficiently. Caliper is aggressively innovating new technology to bridge the gap between in vitro assays and in vivo results and then translating those results into cures for human disease. Caliper's portfolio of offerings includes state-of-the-art microfluidics, lab automation and liquid handling, optical imaging technologies, and discovery and development outsourcing solutions. For more information please visit www.caliperLS.com.

Caliper is a registered trademark of Caliper Life Sciences, Inc.

SOURCE Caliper Life Sciences, Inc.



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES